去甲替林增强神经病理性大鼠吗啡条件性位置偏爱:中枢去甲肾上腺素能系统的作用
本研究在 naive 与慢性坐骨神经缩窄损伤(CCI)大鼠中,用条件性位置偏爱(CPP)评估去甲替林是否影响吗啡奖赏效应,并用 PCR、Western blot 和 ELISA 探讨中枢去甲肾上腺素能系统。结果显示 naive 大鼠中共给药不改变吗啡 CPP 获得,而 CCI 大鼠中去甲替林增强 CPP 获得、延迟消退并增强复燃,伴蓝斑 α2A 受体、去甲肾上腺素转运体和酪氨酸羟化酶表达降低及伏隔核去甲肾上腺素浓度升高。
要点
- 在 CCI 神经病理性大鼠中,去甲替林增强吗啡奖赏并延迟其消退。
- naive 大鼠中去甲替林与吗啡共给药不改变吗啡 CPP 获得。
- 该行为表型可能与中枢去甲肾上腺素能系统上调有关。
核心结论
- 去甲替林在 CCI 神经病理性大鼠中增强吗啡奖赏,该行为表型可能由中枢去甲肾上腺素能系统上调介导。
研究设计与样本
- 研究在 naive 与慢性坐骨神经缩窄损伤(CCI)大鼠中,用条件性位置偏爱(CPP)评估药物奖赏效应。
- 采用实时聚合酶链反应、Western blot 和酶联免疫吸附分析探讨中枢去甲肾上腺素能系统功能。
主要发现
- naive 大鼠中去甲替林与吗啡共给药不改变吗啡诱导 CPP 的获得。
- CCI 大鼠中去甲替林增强吗啡诱导 CPP 的获得、延迟其消退并增强其复燃。
- CCI 大鼠去甲替林与吗啡共给药后,蓝斑 α2A 肾上腺素能受体、去甲肾上腺素转运体和酪氨酸羟化酶表达明显降低,伏隔核去甲肾上腺素浓度明显升高。
临床怎么用
- 在神经病理性疼痛大鼠中,去甲替林与吗啡联用可能增强吗啡奖赏,提示临床联合用药时需关注阿片类药物的奖赏效应。
局限性
- 研究为动物实验,结论外推至临床需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Combination drug therapy is commonly used to treat chronic pain conditions such as neuropathic pain, and antidepressant is often used together with opioid analgesics. While rewarding is an intrinsic property of opioid analgesics, it is unknown whether the use of an antidepressant would influence opioid reward, which may contribute to opioid addiction. In this study, we examined whether nortriptyline (a tricyclic antidepressant and a first-line medication for neuropathic pain) would enhance the morphine rewarding property in both naive and chronic constriction sciatic nerve injury (CCI) rats. METHODS: The rewarding effect of these drugs was assessed using conditioned place preference (CPP). The real-time polymerase chain reaction, western blot, and enzyme-linked immunosorbent assay analysis were used to investigate the function of central noradrenergic system. RESULTS: In naive rats, coadministration of nortriptyline with morphine did not change the acquisition of morphine-induced CPP. However, nortriptyline enhanced the acquisition, delayed the extinction, and augmented the reinstatement of morphine-induced CPP in CCI rats. In CCI rats treated with both nortriptyline and morphine, the expression of α2A-adrenergic receptors, norepinephrine transporter, and tyrosine hydroxylase was markedly decreased in the locus coeruleus, whereas the norepinephrine concentration in the nucleus accumbens was remarkably increased. CONCLUSIONS: These results demonstrate that nortriptyline enhanced morphine reward when both drugs were used to treat neuropathic pain in rats and that this behavioral phenotype is likely to be mediated by upregulation of the central noradrenergic system. These findings may have implications in opioid therapy commonly used for chronic pain management.
引用
- Mi W, Wang S, You Z, et al. Nortriptyline Enhances Morphine-Conditioned Place Preference in Neuropathic Rats: Role of the Central Noradrenergic System. Anesth Analg. 2017. PMID: 28537967. doi:10.1213/ANE.0000000000002128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。